429 related articles for article (PubMed ID: 25449711)
1. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.
Heckers S; Konradi C
Schizophr Res; 2015 Sep; 167(1-3):4-11. PubMed ID: 25449711
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal neurons in schizophrenia.
Heckers S; Konradi C
J Neural Transm (Vienna); 2002 May; 109(5-6):891-905. PubMed ID: 12111476
[TBL] [Abstract][Full Text] [Related]
3. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism.
Braun I; Genius J; Grunze H; Bender A; Möller HJ; Rujescu D
Schizophr Res; 2007 Dec; 97(1-3):254-63. PubMed ID: 17601703
[TBL] [Abstract][Full Text] [Related]
4. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.
Nguyen R; Morrissey MD; Mahadevan V; Cajanding JD; Woodin MA; Yeomans JS; Takehara-Nishiuchi K; Kim JC
J Neurosci; 2014 Nov; 34(45):14948-60. PubMed ID: 25378161
[TBL] [Abstract][Full Text] [Related]
5. GABA abnormalities in schizophrenia: a methodological review of in vivo studies.
Taylor SF; Tso IF
Schizophr Res; 2015 Sep; 167(1-3):84-90. PubMed ID: 25458856
[TBL] [Abstract][Full Text] [Related]
6. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.
Lin H; Hsu FC; Baumann BH; Coulter DA; Anderson SA; Lynch DR
Mol Cell Neurosci; 2014 Jul; 61():163-75. PubMed ID: 24983521
[TBL] [Abstract][Full Text] [Related]
7. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology.
Schubert KO; Föcking M; Cotter DR
Schizophr Res; 2015 Sep; 167(1-3):64-72. PubMed ID: 25728835
[TBL] [Abstract][Full Text] [Related]
8. Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency.
Boksa P; Zhang Y; Nouel D; Wong A; Wong TP
Dev Neurosci; 2016; 38(5):342-353. PubMed ID: 28214898
[TBL] [Abstract][Full Text] [Related]
9. The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophrenia.
Nakamura JP; Schroeder A; Hudson M; Jones N; Gillespie B; Du X; Notaras M; Swaminathan V; Reay WR; Atkins JR; Green MJ; Carr VJ; Cairns MJ; Sundram S; Hill RA
Brain Behav Immun; 2019 Oct; 81():161-171. PubMed ID: 31175998
[TBL] [Abstract][Full Text] [Related]
10. Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia.
Berretta S; Munno DW; Benes FM
J Comp Neurol; 2001 Mar; 431(2):129-38. PubMed ID: 11169995
[TBL] [Abstract][Full Text] [Related]
11. The GABA-glutamate connection in schizophrenia: which is the proximate cause?
Coyle JT
Biochem Pharmacol; 2004 Oct; 68(8):1507-14. PubMed ID: 15451393
[TBL] [Abstract][Full Text] [Related]
12. Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models.
Reynolds GP; Abdul-Monim Z; Neill JC; Zhang ZJ
Neurotox Res; 2004; 6(1):57-61. PubMed ID: 15184106
[TBL] [Abstract][Full Text] [Related]
13. A rodent model of schizophrenia derived from postmortem studies.
Berretta S; Gisabella B; Benes FM
Behav Brain Res; 2009 Dec; 204(2):363-8. PubMed ID: 19539659
[TBL] [Abstract][Full Text] [Related]
14. Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.
Gilani AI; Chohan MO; Inan M; Schobel SA; Chaudhury NH; Paskewitz S; Chuhma N; Glickstein S; Merker RJ; Xu Q; Small SA; Anderson SA; Ross ME; Moore H
Proc Natl Acad Sci U S A; 2014 May; 111(20):7450-5. PubMed ID: 24794528
[TBL] [Abstract][Full Text] [Related]
15. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
[TBL] [Abstract][Full Text] [Related]
16. Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia.
Alvarez RJ; Pafundo DE; Zold CL; Belforte JE
J Neurosci; 2020 Apr; 40(16):3304-3317. PubMed ID: 32205341
[TBL] [Abstract][Full Text] [Related]
17. alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons.
Buhler AV; Dunwiddie TV
J Neurophysiol; 2002 Jan; 87(1):548-57. PubMed ID: 11784770
[TBL] [Abstract][Full Text] [Related]
18. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.
Modinos G; Şimşek F; Azis M; Bossong M; Bonoldi I; Samson C; Quinn B; Perez J; Broome MR; Zelaya F; Lythgoe DJ; Howes OD; Stone JM; Grace AA; Allen P; McGuire P
Neuropsychopharmacology; 2018 Dec; 43(13):2652-2659. PubMed ID: 29440719
[TBL] [Abstract][Full Text] [Related]
19. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
Kimoto S; Zaki MM; Bazmi HH; Lewis DA
JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
Abekawa T; Ito K; Nakagawa S; Koyama T
Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]